drugset / Trial / NCT03541655
Safety and Activity of F14 for Management of Pain Following Total Knee Replacement
RandomizedParallel-groupSingle-blindTreatment
Summary
The safety and activity of a single, 3.5 mL dose of F14 (celecoxib) concurrent with standard of care analgesia administered following total knee replacement will be compared to standard of care analgesia alone.
Timeline
- Start
- 2018-05-04
- Primary completion
- 2019-06-20
- Completion
- 2020-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | F14 | Unknown | 3.5 ml | Other |
| Background | Bupivacaine | Other / unclassified | 0.25 % | — |
Indications
No indication recorded.